Institutional investors purchased a net $24.0 million shares of SNTA during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 30.73% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MCQUEEN, BALL & ASSOCIATES, INC. Bought 102.7 Thousand shares of Synta Pharmaceuticals Cor...